Paris, France

Ali Jafarshad


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ali Jafarshad

Introduction

Ali Jafarshad is a notable inventor based in Paris, France. He has made significant contributions to the field of medical science, particularly in the development of vaccines. His work focuses on improving vaccine potential against malaria, a disease that poses a serious health threat worldwide.

Latest Patents

Ali Jafarshad holds a patent for a sub-region of a plasmodium protein with improved vaccine potential and medical uses. The patent, titled "Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof," relates to a sub-region of a protein that enhances vaccine efficacy. This invention provides unstructured or unfolded polypeptides derived from the PFF0165c protein of 3D7. The polypeptides exhibit high antigenicity, high immunogenicity, and significant parasite-killing activity in the ADCI assay. They are strongly associated with clinical protection against malaria, making them particularly beneficial for infants, toddlers, children under the age of 5, and pregnant women.

Career Highlights

Throughout his career, Ali Jafarshad has worked with prestigious institutions such as Institut Pasteur and Université De Lausanne. His experience in these organizations has allowed him to contribute to groundbreaking research in the field of immunology and vaccine development.

Collaborations

Ali has collaborated with esteemed colleagues, including Pierre Druilhe and Giampietro Corradin. These partnerships have further enriched his research and innovation in the medical field.

Conclusion

Ali Jafarshad's work exemplifies the impact of innovative thinking in addressing global health challenges. His contributions to malaria vaccine development highlight the importance of scientific research in improving public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…